NanoViricides Inc. (NNVC)

[KuChing]

Now that's what I'm talking about.

Nice boat load of links to FluCide info.

Based on the excerpt below, from the last link dated May 26 2009, I would think that Thevac LLC will have some Flucide results on H1N1 to report out soon. The PR announcing the start of EKC studies at Thevac which also started the Herpes study, was published on June 15th 2009.

NanoViricides, Inc. (OTC BB: NNVC.OB) (the "Company"), announced today that it has signed a pre-clinical study agreement for the evaluation of FluCide, NanoViricides` universal anti-influenza drug candidate. The study will be
conducted by Thevac, LLC, a spin-off of the Louisiana State University (LSU), Baton Rouge, LA. It will be performed in collaboration with the Division of Biotechnology and Molecular Medicine at the LSU School of Veterinary Medicine,
which administers the LSU-Tulane Center for Experimental Infectious Disease Research (Director, K. G. Kousoulas, PhD)